rs77039439

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1

The NM_001366110.1(PAX4):​c.474C>T​(p.Gly158Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0588 in 1,613,926 control chromosomes in the GnomAD database, including 3,209 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.046 ( 201 hom., cov: 30)
Exomes 𝑓: 0.060 ( 3008 hom. )

Consequence

PAX4
NM_001366110.1 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 0.211

Publications

7 publications found
Variant links:
Genes affected
PAX4 (HGNC:8618): (paired box 4) This gene is a member of the paired box (PAX) family of transcription factors. Members of this gene family typically contain a paired box domain, an octapeptide, and a paired-type homeodomain. These genes play critical roles during fetal development and cancer growth. The paired box 4 gene is involved in pancreatic islet development and mouse studies have demonstrated a role for this gene in differentiation of insulin-producing beta cells. [provided by RefSeq, Jul 2008]
PAX4 Gene-Disease associations (from GenCC):
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • diabetes mellitus, noninsulin-dependent
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • maturity-onset diabetes of the young type 9
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • monogenic diabetes
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 7-127613844-G-A is Benign according to our data. Variant chr7-127613844-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 129876.We mark this variant Benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BP7
Synonymous conserved (PhyloP=0.211 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0673 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAX4NM_001366110.1 linkc.474C>T p.Gly158Gly synonymous_variant Exon 7 of 12 ENST00000639438.3 NP_001353039.1
PAX4NM_001366111.1 linkc.474C>T p.Gly158Gly synonymous_variant Exon 5 of 10 NP_001353040.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAX4ENST00000639438.3 linkc.474C>T p.Gly158Gly synonymous_variant Exon 7 of 12 5 NM_001366110.1 ENSP00000491782.1 A0A1W2PPX4

Frequencies

GnomAD3 genomes
AF:
0.0456
AC:
6927
AN:
152004
Hom.:
201
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0118
Gnomad AMI
AF:
0.0559
Gnomad AMR
AF:
0.0298
Gnomad ASJ
AF:
0.0582
Gnomad EAS
AF:
0.000580
Gnomad SAS
AF:
0.0131
Gnomad FIN
AF:
0.0837
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0689
Gnomad OTH
AF:
0.0402
GnomAD2 exomes
AF:
0.0461
AC:
11594
AN:
251452
AF XY:
0.0462
show subpopulations
Gnomad AFR exome
AF:
0.0113
Gnomad AMR exome
AF:
0.0245
Gnomad ASJ exome
AF:
0.0574
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0790
Gnomad NFE exome
AF:
0.0668
Gnomad OTH exome
AF:
0.0458
GnomAD4 exome
AF:
0.0602
AC:
88011
AN:
1461804
Hom.:
3008
Cov.:
33
AF XY:
0.0589
AC XY:
42798
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.00956
AC:
320
AN:
33480
American (AMR)
AF:
0.0251
AC:
1124
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0551
AC:
1440
AN:
26136
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.0133
AC:
1146
AN:
86258
European-Finnish (FIN)
AF:
0.0758
AC:
4050
AN:
53412
Middle Eastern (MID)
AF:
0.0166
AC:
96
AN:
5768
European-Non Finnish (NFE)
AF:
0.0688
AC:
76549
AN:
1111932
Other (OTH)
AF:
0.0543
AC:
3282
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
4507
9013
13520
18026
22533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2732
5464
8196
10928
13660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0455
AC:
6928
AN:
152122
Hom.:
201
Cov.:
30
AF XY:
0.0453
AC XY:
3366
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.0117
AC:
487
AN:
41510
American (AMR)
AF:
0.0298
AC:
455
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0582
AC:
202
AN:
3472
East Asian (EAS)
AF:
0.000581
AC:
3
AN:
5160
South Asian (SAS)
AF:
0.0133
AC:
64
AN:
4820
European-Finnish (FIN)
AF:
0.0837
AC:
887
AN:
10598
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0689
AC:
4685
AN:
67968
Other (OTH)
AF:
0.0398
AC:
84
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
314
628
943
1257
1571
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0578
Hom.:
145
Bravo
AF:
0.0410
Asia WGS
AF:
0.00577
AC:
20
AN:
3478
EpiCase
AF:
0.0662
EpiControl
AF:
0.0608

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 27, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 08, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Maturity onset diabetes mellitus in young Uncertain:1Benign:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

This PAX4 gene is associated with MODY, however, no association is found between this particular variant (rs77039439) of PAX4 gene and MODY yet. It needs further validation via clinical studies. -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
3.4
DANN
Benign
0.51
PhyloP100
0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77039439; hg19: chr7-127253898; COSMIC: COSV107439472; API